Clinical and genetic findings in 26 Italian patients with Lafora disease

Epilepsia
Silvana FranceschettiF Zara

Abstract

EPM2B mutations have been found in a variable proportion of patients with Lafora disease (LD). Genotype-phenotype correlations suggested that EPM2B patients show a slower course of the disease, with delayed age at death, compared with EPM2A patients. We herein report clinical and genetic findings of 26 Italian LD patients. Disease progression was evaluated by means of a disability scale based on residual motor and cognitive functions and daily living and social abilities, at 4 years from the onset. Mutational analysis was performed by sequencing the coding regions of the EPM2A and EPM2B genes. Age at onset ranged from 8.5 to 18.5 years (mean, 13.7+/-2.6). The mean duration of follow-up was 7.1+/-3.9 years. Daily living activities and social interactions were preserved in five of 24 patients. The remaining patients showed moderate to extremely severe limitations of daily living and social abilities. Sixteen (72%) of 22 families showed mutations in the EPM2B gene, and five (22%), in the EPM2A gene. One family showed no mutations. A novel EPM2B mutation also was identified. In our series, EPM2B mutations occurred in 72% of families, thus indicating that EPM2B is the major gene for LD in the Italian population. Moreover, we found t...Continue Reading

References

Jan 1, 1993·Archives of Neurology·I DruryA Beydoun
Sep 6, 2003·Nature Genetics·Elayne M ChanStephen W Scherer
Mar 23, 2005·Neurology·C Gómez-AbadJ M Serratosa

❮ Previous
Next ❯

Citations

Apr 21, 2011·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Philippe CouarchStéphanie Baulac
Mar 30, 2012·Journal of Human Genetics·Shweta Singh, Subramaniam Ganesh
May 30, 2009·Epilepsia·Federico Zara, Amedeo Bianchi
Aug 27, 2010·Epilepsia·Gaetan LescaPierre Genton
Jul 9, 2011·PloS One·Rosa GuerreroPilar Gómez-Garre
Jun 10, 2010·CNS Drugs·Thomas S Monaghan, Norman Delanty
Jun 17, 2009·Expert Opinion on Pharmacotherapy·Danielle M AndradeBerge A Minassian
Feb 11, 2015·Epilepsy & Behavior Case Reports·Hélène-Marie LanoiseléeBertrand De Toffol
Nov 16, 2010·Annals of Neurology·Julie TurnbullBerge A Minassian
Jul 21, 2012·IUBMB Life·Carlos Romá-MateoMatthew S Gentry
Mar 1, 2006·Epilepsy Research·Simonetta CardinaliPierangelo Veggiotti
Oct 2, 2014·Epilepsia·Edoardo FerlazzoUmberto Aguglia
Sep 24, 2014·Epilepsy Research·Aurelio Jara-PradoIris E Martínez-Juárez
Jul 28, 2016·Epilepsy & Behavior : E&B·Danielle Goldsmith, Berge A Minassian
Jun 14, 2016·Annals of Indian Academy of Neurology·Rajendra Singh JainRakesh Agrawal
May 31, 2017·The International Journal of Neuroscience·Sara CasciatoGiancarlo Di Gennaro
Jul 13, 2014·Journal of Child Neurology·Hatice Gamze PoyrazoğluSefer Kumandas
Feb 12, 2008·Journal of Child Neurology·Julie TurnbullBerge A Minassian
Aug 12, 2017·International Journal of Molecular Sciences·Mitchell A SullivanFelix Nitschke
Jan 17, 2020·Expert Review of Neurotherapeutics·Marcello ScalaPasquale Striano
Dec 21, 2019·European Journal of Nuclear Medicine and Molecular Imaging·Lorenzo MuccioliFrancesca Bisulli
Jun 9, 2018·Epilepsia Open·Danielle Goldsmith, Berge A Minassian
Aug 26, 2018·Nature Reviews. Neurology·Felix NitschkeBerge A Minassian
Jul 28, 2018·Cells·Maria Adelaida García-GimenoPascual Sanz
Sep 26, 2019·Frontiers in Neurology·Sarah MartinKarl Martin Klein
Jun 23, 2019·Orphanet Journal of Rare Diseases·Francesca BisulliPaolo Tinuper
Dec 4, 2019·Molecular Genetics and Metabolism·Benjamin L FarahDwight D Koeberl
Mar 28, 2021·Journal of the Neurological Sciences·Antonella RivaUNKNOWN Italian League Against Epilepsy Genetic Commission
Jun 13, 2021·Journal of Human Genetics·Garen HaryanyanNerses Bebek
Aug 18, 2021·Orphanet Journal of Rare Diseases·Federica PondrelliFrancesca Bisulli
Sep 7, 2021·Journal of Veterinary Internal Medicine·Thomas FlegelJosephine Dietzel
Nov 11, 2021·IScience·M Kathryn BrewerMatthew S Gentry

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.